Results 261 to 270 of about 354,322 (345)
A Very Rare Relaps Type in Multiple Myeloma: Leptomenıngeal and Cranial Involvement
Orhan Ayyıldız, Songül Beskisiz
openalex +2 more sources
ABSTRACT Allogeneic hematopoietic stem cell transplantation (HSCT) is increasingly used to treat malignant and non‐malignant diseases. Following allogeneic HSCT, patients are particularly vulnerable to vaccine‐preventable diseases (VPD) because conditioning depletes immune cells, including memory cells.
Hélène Buvelot +3 more
wiley +1 more source
Sex differences in the clinical presentation of patients with newly diagnosed multiple myeloma. [PDF]
Ong KL +6 more
europepmc +1 more source
ABSTRACT Background Severe renal insufficiency requiring dialysis in newly diagnosed multiple myeloma (NDMM) patients has been independently associated with poor survival outcomes. However, there is a paucity of data on factors predicting renal recovery and survival outcomes of these patients.
Rintu Sharma +13 more
wiley +1 more source
Concomitant Transthyretin Amyloid Cardiomyopathy in Patients With Multiple Myeloma. [PDF]
Ibrahim M +9 more
europepmc +1 more source
ABSTRACT The interplay between the commensal microbiota and the mammalian immune system may influence the outcomes of T cell‐driven cancer immunotherapies. However, clinical studies supporting microbiota‐based interventions in chimeric antigen receptor T‐cell (CAR‐T) therapy remain scarce.
Rafael Hernani +22 more
wiley +1 more source
Oral selinexor–dexamethasone for triple-class refractory multiple myeloma [PDF]
al., et, Vij, Ravi
core +1 more source
Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti‐
Yuekun Qi +22 more
openalex +1 more source
ABSTRACT Background Managing febrile neutropenia is challenging due to the limited sensitivity of blood culture (BC) and the lack of tools differentiating infectious from non‐infectious fever. T2 magnetic resonance (T2MR) is a culture‐independent system detecting bacteria (T2Bacteria) and yeasts (T2Candida); SeptiCyte RAPID is a host response assay ...
Anna Maria Peri +6 more
wiley +1 more source

